Читать книгу Clinical Applications of Optical Coherence Tomography Angiography - Группа авторов - Страница 29

1Shields JA, Shields CL: Intraocular Tumors: An Atlas and Textbook. ed 3. Philadelphia, Lippincott Williams and Wilkins, 2016.

2Shields CL, Kaliki S, Furuta M, et al: American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7,731 patients. Ophthalmology 2013;120:2066–2071.

3Shields CL, Kaliki S, Furuta M, et al: American Joint Committee on Cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman Lecture. Ophthalmology 2015;122:1180–1186.

4Collaborative Ocular Melanoma Study Group: The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 2006;124:1684–1693.

5Shields CL, Furuta M, Thangappan A, et al: Metastasis of uveal melanoma millimeter-by-millimeter in 8,033 consecutive cases. Arch Ophthalmol 2009;127:989–998.

6The Collaborative Ocular Melanoma Study Group: Factors predictive of growth and treatment of small choroidal melanoma. COMS Report No. 5. Arch Ophthalmol 1997;115:1537–1544.

7Shields CL, Cater JC, Shields JA, et al: Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol 2000;118:360–364.

8Shields CL, Shields JA: Clinical features of small choroidal melanoma. Curr Opin Ophthalmol 2002;13:135–141.

9Shields CL, Furuta M, Berman EL, et al: Choroidal nevus transformation into melanoma. Analysis of 2514 consecutive cases. Arch Ophthalmol 2009;127:981–987.

10Shields CL, Shields JA: Clinical features of small choroidal melanoma. Curr Opin Ophthalmol 2002;13:135–141.

11Shields CL, Manalac J, Das C, et al: Choroidal melanoma: clinical features, classification, and top 10 pseudomelanomas. Curr Opin Ophthalmol 2014;25:177–185.

12Butler P, Char DH, Zarbin M, et al: Natural history of indeterminate pigmented choroidal tumors. Ophthalmology 1994;101:710–716.

13Fuller DG, Snyder WB, Hutton WL, Vaiser A: Ultrasonographic features of choroidal malignant melanomas. Arch Ophthalmol 1979;97:1465–1472.

14Goldberg MF, Hodes BL: Ultrasonographic diagnosis of choroidal malignant melanoma. Surv Ophthalmol 1977;22:29–40.

15Shields CL, Shields JA, De Potter P: Patterns of indocyanine green videoangiography of choroidal tumors. Br J Ophthalmol 1995;79:237–245.

16Charamis J, Katsourakis N, Mandras G: The study of the cerebroretinal circulation by intravenous fluorescein injection. Am J Ophthalmol 1966;61:1078–1080.

17Augsburger JJ, Golden MI, Shields JA: Fluorescein angiography of choroidal melanomas with retinal invasion. Retina 1984;4:232–241.

18McCannel TA, Kim E, Kamrava M, et al: New ultra-wide-field angiographic grading scheme for radiation retinopathy after Iodine-125 brachytherapy for uveal melanoma. Retina 2018;38:2415–2421.

19Shields CL, Bianciotto C, Pirondini C, et al: Autofluorescence of orange pigment overlying small choroidal melanoma. Retina 2007;27:1107–1111.

20Shields CL, Bianciotto C, Pirondini C, et al: Autofluorescence of choroidal melanoma in 51 cases. Br J Ophthalmol 2008;92:617–622.

21Muscat S, Parks S, Kemp E, Keating D: Secondary retinal changes associated with choroidal naevi and melanomas documented by optical coherence tomography. Br J Ophthalmol 2004;88:120–124.

22Espinoza G, Rosenblatt B, Harbour JW: Optical coherence tomography in the evaluation of retinal changes associated with suspicious choroidal melanocytic tumors. Am J Ophthalmol 2004;137:90–95.

23Singh AD, Belfort RN, Sayanagi K, Kaiser PK: Fourier domain optical coherence tomographic and auto-fluorescence findings in indeterminate choroidal melanocytic lesions. Br J Ophthalmol 2010;94:474–478.

24Shields CL, Kaliki S, Rojanaporn D, et al: Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus. Arch Ophthalmol 2012;130:850–856.

25Shields CL, Pellegrini M, Ferenczy SR, Shields JA: Enhanced depth imaging optical coherence tomography of intraocular tumors. From placid to seasick to rock and rolling topography – the 2013 Francesco Orzalesi Lecture. Retina 2014;34:1495–1512.

26Mrejen S, Fung AT, Silverman RH, et al: Potential pitfalls in measuring the thickness of small choroidal melanocytic tumors with ultrasonography. Retina 2013;33:1293–1299.

27Horgan N, Shields CL, Mashayekhi A, et al: Early macular morphological changes following plaque radiotherapy for uveal melanoma. Retina 2008;28:263–273.

28Jia Y, Tan O, Tokayer J, et al: Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012;20:4710–5725.

29Spaide RF, Klancnik JM, Cooney MJ: Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 2015;133:45–50.

30Chang AE, Karnell LH, Menck HR: The National Cancer Data Base report on cutaneous and noncutaneou s melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664–1678.

31Shields CL, Kaliki S, Furuta M, et al: Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina 2012;32:1363–1372.

32Singh AD, Topham A: Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 2003;110:956–961.

33Mashayekhi A, Schonbach E, Shields CL, Shields JA: Early subclinical macular edema in eyes with uveal melanoma: association with future cystoid macular edema. Ophthalmology 2015;122:1023–1029.

34Shields CL, Say EAT, Samara WA, et al: Optical coherence tomography angiography of the macula after plaque radiotherapy of choroidal melanoma: comparison of irradiated versus nonirradiated eyes in 65 patients. Retina 2016;36:1493–1505.

35Say EAT, Samara WA, Khoo CT, et al: Parafoveal capillary density after plaque radiotherapy for choroidal melanoma. Analysis of eyes without radiation maculopathy. Retina 2016;36:1670–1678.

36Li Y, Say EAT, Ferenczy SR, et al: Altered parafoveal microvasculature in treatment-naïve choroidal melanoma eyes detected by optical coherence tomography angiography. Retina 2017;37:32–40.

37Valverde-Megias A, Say EAT, Ferenczy SR, Shields CL: Differential macular features on optical coherence tomography angiography in eyes with choroidal nevus and melanoma. Retina 2017;37:731–740.

38Bhardwal S, Tsui E, Zahid S, et al: Value of fractal analysis of optical coherence tomography angiography in various stages of diabetic retinopathy. Retina 2018;38:1816–1823.

39Gadde SGK, Anegondi N, Bhanushali D, et al: Quantification of vessel density in retinal optical coherence tomography angiography images using local fractal dimension. Invest Ophthalmol Vis Sci 2016;57:246–252.

40Matet A, Daruich A, Zografos L: Radiation maculopathy after proton beam therapy for uveal melanoma: optical coherence tomography angiography alterations influencing visual acuity. Invest Ophthalmol Vis Sci 2017;58:3851–3861.

41Han IC, Jaffe GJ: Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology 2010;117:1177–1189.

42Chhablani J, Krishnan T, Sethi V, Kozak I: Artifacts in optical coherence tomography. Saudi J Ophthalmol 2014;28:81–87.

43Spaide RF, Fujimoto JG, Waheed NK: Image artifacts in optical coherence tomography angiography. Retina 2015;35:2163–2180.

44de Carlo TE, Romano A, Waheed NK, Duker JS: A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous 2015;1:5–20.

45Say EAT, Ferenczy SR, Magrath GN, et al: Image quality and artifacts on optical coherence tomography angiography: comparison of pathologic and paired fellow eyes in 65 patients with unilateral choroidal melanoma treated with plaque radiotherapy. Retina 2017;37:1660–1673.

46Cennamo G, Romano MR, Breve MA, et al: Evaluation of choroidal tumors with optical coherence tomography. Enhanced depth imaging and OCT-angiography features. Eye 2017;31:906–915.

47Nesper PL, Lutty GA, Fawzi AA: Residual choroidal vessels in atrophy can masquerade as choroidal neovascularization on optical coherence tomography angiography. Retina 2018;38:1289–1300.

48Missotten GS, Notting IC, Schlingemann R, et al: Vascular endothelial growth factor A in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428–1434.

49Vinores SA, Küchle M, Mahlow J, et al: Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 1995;147:1289–1297.

50Boyd SR, Tan D, Bunce C, et al: Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol 2002;86:448–452.

51Koulisis N, Kim AY, Chu Z, et al: Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography. PLoS One 2017;12:e0176404.

52Noma H, Funatsu H, Mimura T, et al: Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 2009;116:87–93.

53Samara WA, Shahlaee A, Adam MK, et al: Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity. Ophthalmology 2017;124:235–244.

54Lee J, Moon GB, Cho AR, Yoon YH: Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology 2016;123:2368–2375.

55Goudot MM, Sikorav A, Semoun O, et al: Parafoveal oct angiography features in diabetic patients without clinical diabetic retinopathy: a qualitative and quantitative analysis. J Ophthalmol 2017;2017:8676091.

56Chen Qi, Ma Q, Wu C, et al: Macular vascular fractal dimension in the deep capillary layer as an early indicator of microvascular loss for retinopathy in type 2 diabetic patients. Invest Ophthalmol Vis Sci 2017;58:3785–3794.

57Ting DSW, Tan GSW, Agrawal R, et al: Optical coherence tomographic angiography in type 2 diabetes and diabetic retinopathy. JAMA Ophthalmol 2017;135:306–312.

58Gupta N, Mansoor S, Sharma A, et al: Diabetic retinopathy and VEGF. Open Ophthalmol J 2013;7:4–10.

59Skalet AH, Liu L, Binder C, et al: Quantitative OCT angiography evaluation of peripapillary retinal circulation after plaque brachytherapy. Ophthalmol Retina 2018;2:244–250.

60Sioufi K, Say EAT, Ferenczy S, Shields CL: Parafoveal microvascular features on optical coherence tomography angiography in eyes with circumscribed choroidal hemangioma. Retina 2018;38:1091–1099.

61Chetrit M, Bonnin S, Mane V, et al: Acute pseudophakic cystoid macular edema imaged by optical coherence tomography angiography. Retina 2018;38:2073–2080.

62Moein HR, Novais EA, Rebhun CB, et al: Optical coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema. Retina 2018;38:2277–2284.

63Jampol LM, Moy CS, Murray TG, et al: The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002;109:2197–2206.

64Shields CL, Naseripour M, Cater J, et al: Plaque radiotherapy for large posterior uveal melanoma (≥8-mm thick) in 354 consecutive patients. Ophthalmology 2002;109:1838–1849.

65Gunduz K, Shields CL, Shields JA, et al: Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999;127:579–589.

66Gunduz K, Shields CL, Shields JA, et al: Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999;117:609–614.

67Shah SU, Shields CL, Bianciotto CG, et al: Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology 2014;121:269–275.

68Brown GC, Shields JA, Sanborn G, et al: Radiation retinopathy. Ophthalmology 1982;89:1494–1501.

69Horgan N, Shields CL, Mashayekhi A, Shields JA: Classification and treatment of radiation maculopathy. Curr Opin Ophthalmol 2010;21:233–238.

70Kinyoun JL, Lawrence BS, Barlow WE: Proliferative radiation retinopathy. Arch Ophthalmol 1996;114:1097–1100.

71Boldt HC, Melia BM, Liu JC, Reynolds SM; Collaborative Ocular Melanoma Study Group: I-125 brachytherapy for choroidal melanoma: photographic and angiographic abnormalities. The Collaborative Ocular Melanoma Study: COMS Report No. 30. Ophthalmology 2009;116:106–115.

72Bianciotto C, Shields CL, Pirondini C, et al: Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology 2010;117:1005–1012.

73Diabetic Retinopathy Clinical Research Network: Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol 2006;124:1701–1707.

74Diabetic Retinopathy Clinical Research Network: Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007;114:1520–1525.

75Veverka KK, AbouChehade JE, Iezzi R Jr, Pulido JS: Noninvasive grading of radiation retinopathy: the use of optical coherence tomography angiography. Retina 2015;35:2400–2410.

76Finger PT, Kurli M: Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 2005;89:144–149.

77Sellam A, Coscas F, Rouic LLL, et al: Optical coherence tomography angiography of macular features after proton beam radiotherapy for small choroidal melanoma. Am J Ophthalmol 2017;181:12–19.

78Ishibazawa A, Nagaoka T, Yokota H, et al: Characteristics of retinal neovascularization in proliferative diabetic retinopathy imaged by optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2016;57:6247–6255.

79Salz DA, de Carlo TE, Adhi M, et al: Select features of diabetic retinopathy on swept source optical coherence tomographic angiography compared with fluorescein angiography and normal eyes. JAMA Ophthalmol 2016;134:644–650.

80Magrath GN, Say EAT, Sioufi K, et al: Variability in foveal avascular zone and capillary density using optical coherence tomography angiography machines in healthy eyes. Retina 2016;37:2102–2111.

81Told R, Ginner L, Hecht A, et al: Comparative study between a spectral domain and a high-speed single-beam swept source OCTA system for identifying choroidal neovascularization in AMD. Sci Rep 2016;6:38132.

82Hirano T, Kakihara S, Toriyama Y, et al: Wide-field en face swept-source optical coherence tomography angiography using extended field imaging in diabetic retinopathy. Br J Ophthalmol 2018;102:1199–1203.

83Uji A, Balasubramanian S, Lei J, et al: Impact of multiple en face image averaging on quantitative assessment from optical coherence tomography angiography images. Ophthalmology 2017;124:944–952.

84Uji A, Balasubramanian S, Lei J, et al: Choriocapillaries imaging using multiple en face optical coherence tomography angiography image averaging. JAMA Ophthalmol 2017;135:1197–1204.

Dr. Emil Anthony T. Say

Retina Service, Medical University of South Carolina (MUSC)

167 Ashley Ave, MSC 676

Charleston SC, 29425 (USA)

E-Mail saye@musc.edu

Dr. Carol L. Shields

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University

840 Walnut Street, Suite 1440

Philadelphia, PA 19107 (USA)

E-Mail carolshields@gmail.com